<DOC>
	<DOCNO>NCT01420510</DOCNO>
	<brief_summary>We hypothesise use Adelmidrol ( Saginil vaginal cannula ) reduce incidence magnitude vaginitis patient affect gynecologic malignancy .</brief_summary>
	<brief_title>Saginil v . Placebo Gynecologic Oncology Patients Affected Vaginitis</brief_title>
	<detailed_description />
	<mesh_term>Vaginitis</mesh_term>
	<criteria>Gynecologic malignancy Current administration chemotherapy Colpectomy Vaginal cancer Vulvar cancer Bacterial vaginitis</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Patients satisfaction</keyword>
	<keyword>Side effect</keyword>
</DOC>